Connect Biopharma Holdings Ltd. (CNTB)
2.07
+0.06
(+2.99%)
USD |
NASDAQ |
Sep 10, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings EPS Diluted (Quarterly) : -0.2749 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2749 |
| March 31, 2026 | -0.343 |
| December 31, 2025 | -0.2695 |
| Date | Value |
|---|---|
| September 30, 2025 | -0.3087 |
| June 30, 2025 | -0.2324 |
| March 31, 2025 | -0.1856 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.28M |
| Revenue (Quarterly) | 2.768M |
| Total Expenses (Quarterly) | 20.05M |
| Enterprise Value | 95.69M |
| Profit Margin (Quarterly) | -624.4% |
| Earnings Yield | -57.78% |
| Normalized Earnings Yield | -57.78 |